Tokyo Metropolitan Neurological Hospital

Recent papers from Tokyo Metropolitan Neurological Hospital

1. Nadir Prolactin–guided Individualized Cabergoline Therapy Achieves Durable Remission and Safe Pregnancy in ProlactinomasThe Journal of Clinical Endocrinology & Metabolism · 2026
2. Inhibition of Abnormal Elevated α‐Synuclein Ameliorates Dopaminergic Neuron Degeneration in Parkinson's Disease Mouse ModelAging Cell · 2026
3. Comment on the Cerebral Astrocytic Inclusion Pathology in Multiple System Atrophy With a Long Clinical CourseNeuropathology · 2026
4. Autoantibody Profiles of Immune Checkpoint Inhibitor-Associated Myasthenia and MyositisCancer Control · 2026
5. AOSNP‐ADAPTR resource level‐based recommendations on practical diagnostic strategies for medulloblastomas and other embryonal tumorsBrain Pathology · 2026
6. Gold Coast criteria for ALS diagnosis: individual participant data meta-analysisJournal of Neurology · 2026
7. Clinical and molecular characteristics of thalamic gliomas in adults: prognostic impact of TERT promoter mutationNeurosurgical Review · 2026
8. Nutritional Factors and Weight Loss Predict Tracheostomy‐Free Survival in Multiple System AtrophyMovement Disorders Clinical Practice · 2026
9. Sensory Cortical Hyperexcitability in Amyotrophic Lateral Sclerosis Involves a Broad Hand Representation Within the Primary Somatosensory CortexMuscle & Nerve · 2026
10. Splenial corpus callosum lesions in Boucher–Neuhäuser syndrome: a case series and comprehensive literature review with exploratory analysis of disease durationNeuroradiology · 2026
11. Comprehensive Care Goals in Myasthenia GravisNeurology Clinical Practice · 2026
12. Autopsy-Confirmed Non-Paraneoplastic Lambert–Eaton Myasthenic Syndrome with Cerebellar Degeneration: A Case ReportDiagnostics · 2026
13. An Autopsy Report of Beta-Propeller Protein-Associated Neurodegeneration with 68-Year Survival, Focusing on Isoform-Specific Distribution of Hyperphosphorylated TauReports — Medical Cases Images and Videos · 2026
14. Multidisciplinary recommendations for palliative and supportive care in Creutzfeldt-Jakob disease and related disordersAge and Ageing · 2026
15. Long-term effectiveness, safety, and cost-effectiveness of intravenous immunoglobulin for generalized myasthenia gravis in an era of molecular targeted drugs: Insights from Japanese post-marketing surveillanceJournal of Autoimmunity · 2026
16. Treatment Goals in Myasthenia Gravis: Expert Consensus Recommendations Using the RAND/UCLA Appropriateness Method (P4-9.004)Neurology · 2026
17. AOSNP‐ADAPTR resource level‐based recommendations on practical diagnostic strategies for ependymomasBrain Pathology · 2026
18. Sensitivity and Specificity of Cerebrospinal Fluid Placental Alkaline Phosphatase in Germinoma: An 8 pg/mL ThresholdNeuro-Oncology Advances · 2026
19. Neurologic immune-related adverse events from immune checkpoint inhibitors: recent advances and future prospectivesImmunological Medicine · 2026
20. A multicenter randomized phase III study for newly diagnosed, maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide versus chemoradiotherapy alone: Japan Clinical Oncology Group study JCOG1703 (MACS study).Journal of Clinical Oncology · 2026